Wind-down of stem-cell institute leaves a void

Funds paved the way for rigorous tests of therapies, but unintentionally boosted a market for potentially dangerous fakes, says Jeanne F. Loring. Funds paved the way for rigorous tests of therapies, but unintentionally boosted a market for potentially dangerous fakes, says Jeanne F. Loring. “Future advertising must emphasise the necessity of rigorous scientific evidence alongside the potential of the cells.”